Should Lipids Be Monitored during the First Year of Treatment with an Atypical Antipsychotic?

Osser DN Najarian DM Dufresne RL . Olanzapine increases weight and serum triglyceride levels. J Clin Psychiatry 1999;60:767–70.

Henderson DC Cagliero E Gray C Nasrallah RA Hayden D Schoenfeld DA . Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 2000;157:975–81.

Meyer JM . Novel antipsychotics and severe hyperlipidemia. J Clin Psychopharmacol 2001;21:369–74.

Meyer JM . A retrospective comparison of weight, lipid, and glucose changes between risperidone and olanzapine-treated inpatients: Metabolic outcomes after 1 year. J Clin Psychiatry 2002;63:425–33.

Glick ID Berg PH . Time to study discontinuation, relapse, and compliance with atypical or conventional antipsychotics in schizophrenia and related disorders. Int Clin Psychopharmacol 2002;17:65–8.

Binder RL McNiel DE Sandberg DA . A naturalistic study of clinical use of risperidone. Psychiatric Services 1998;49:524–6.

Landry P Benaliouad F. Clinical use of atypical antipsychotic in the first year of treatment: A naturalistic study. Forthcoming.